Gene expression of Lymphoblastoid Cell Lines–LCLs from Depressed Patients after in-vitro treatment with citalopram–CTP. Gene expression of Lymphoblastoid Cell Lines–LCLs from Depressed Patients after in-vitro treatment with citalopram–CTP

We used whole gene gene expression profiling to identify potential gene expression biomarkers associated for the treatment individualization of unipolar depression. Overall design: Gene expression was measured after 24 and 48 hours of in-vitro treatment with 3 µM CTP in n=17 LCLs derived from depressed patients with documented clinical treatment outcome to SSRIs.